Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model

Key Points. Deletion of BM Tfr2 ameliorates anemia and iron overload in a murine model of transfusion-independent thalassemia.Deletion of Tfr2 enhances transcr

Saved in:

Bibliographic Details
Main Authors:	Artuso, Irene (Author) , Lidonnici, Maria Rosa (Author) , Altamura, Sandro (Author) , Mandelli, Giacomo (Author) , Pettinato, Mariateresa (Author) , Muckenthaler, Martina (Author) , Silvestri, Laura (Author) , Ferrari, Giuliana (Author) , Camaschella, Clara (Author) , Nai, Antonella (Author)
Format:	Article (Journal)
Language:	English
Published:	September 12, 2018
In:	Blood Year: 2018, Volume: 132, Issue: 21, Pages: 2286-2297
ISSN:	1528-0020
DOI:	10.1182/blood-2018-05-852277
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1182/blood-2018-05-852277 Verlag, lizenzpflichtig, Volltext: https://ashpublications.org/blood/article/132/21/2286/39548/Transferrin-receptor-2-is-a-potential-novel
Author Notes:	Irene Artuso, Maria Rosa Lidonnici, Sandro Altamura, Giacomo Mandelli, Mariateresa Pettinato, Martina U. Muckenthaler, Laura Silvestri, Giuliana Ferrari, Clara Camaschella, and Antonella Nai

Description
Summary:	Key Points. Deletion of BM Tfr2 ameliorates anemia and iron overload in a murine model of transfusion-independent thalassemia.Deletion of Tfr2 enhances transcr
Item Description:	Gesehen am 08.06.2020
Physical Description:	Online Resource
ISSN:	1528-0020
DOI:	10.1182/blood-2018-05-852277